Reply to: Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia

Affiliations

• ¹ Division of Geriatrics, University of California San Francisco, San Francisco, California, USA.
• ² San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
• ³ Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
• ⁴ University of Washington Department of Epidemiology, Seattle, Washington, USA.
• ⁵ Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.